ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
The new research introduces a different strategy: rather than trying to overcome resistance, the scientists use it as a ...
A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center ...
Early tests show stem cells can be used to spark expression of a miniature version of the dystrophin protein. The combination of gene editing and patient-specific stem cells may offer a new ray of ...
The prothrombin gene mutation increases your risk of severe blood clots. Medications, regular checkups, and healthy lifestyle habits can help reduce this risk. The prothrombin gene plays a crucial ...
Scientists have identified mutations in the CPD gene as a key cause of a rare congenital hearing loss, revealing how disruptions in arginine and nitric oxide signaling damage sensory cells in the ear.
News Medical on MSN
Researchers identify Rb1 as a predictive biomarker for a new therapeutic strategy in some breast cancers
A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center details a therapeutic vulnerability in patients with an aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback